| 1 |
Comparative Assessment of the Long-Term Effectiveness and Safety of Dapagliflozin and Empagliflozin as Add-on Therapy to Hypoglycemic Drugs in Patients with Type 2 Diabetes |
|
| | Ai-Yu Yang, Hung-Chun Chen, Maria Mirabelli | | | Journal of Diabetes Research. 2022; 2022: 1 | | | [Pubmed] [Google Scholar] [DOI] | |
|
